Colorectal Cancer Clinical Trials

Colorectal cancer clinical trials are valuable tools that allow patients to benefit from new treatments as soon as they become available. At the same time, these important research studies help scientists and physicians improve the standard of care. During a trial, if a new treatment is found to be more effective than the currently available options, that treatment may become the new standard. In fact, all of today’s standard treatments were chosen based on the results of past clinical trials.

Patients who participate in colorectal cancer clinical trials at Moffitt Cancer Center can feel confident that they will:

  • Receive the best possible treatment to meet their individual needs in the form of either newly discovered therapies or the current standard of care
  • Be evaluated and monitored by a multispecialty team of cancer experts who will adhere to a carefully designed testing protocol and make highly individualized, evidence-based recommendations
  • Benefit other colorectal cancer patients by helping to improve the standard of care

Through our ongoing research efforts and robust portfolio of clinical trials, Moffitt is achieving better cancer outcomes and providing our patients with higher-quality lives. We are also continually moving forward by identifying causes, developing prevention strategies and discovering new and better treatments for colorectal cancer. As a result of this commitment, Moffitt has earned the distinction of being the only National Cancer Institute-designated Comprehensive Cancer Center based in Florida, a prestigious designation that is nationally recognized by medical professionals and patients alike. Thousands of patients come to Moffitt for innovative treatments and compassionate care.

If you’d like to learn more about the current colorectal cancer clinical trials at Moffitt, you do not need a referral. Call 1-813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.

 

calledFromCancerPage=True - substr=colorectal
testProtocol=

Open Clinical Trials:

Showing of 50

CLINICAL TRIAL 17431

A Randomized Phase 3 Study of the Efficacy and Safety of Glufosfamide Compared with Fluorouracil (5-FU) in Patients with Metastatic Pancreatic Adenocarcinoma Previously Treated with Gemcitabine

Disease Site: Colon, Liver, Lung, Other Endocrine System, Pancreas, Small Intestine, Stomach

View Trial Details

CLINICAL TRIAL 20345

Phase I/II Trial of Pre-Operative Image Guided Intensity Modulated Proton Radiation Therapy (IMPT) or Photon (IMRT) with Simultaneously Integrated Boost to the High Margin for Retroperitoneal Sarcomas

Disease Site: Anal, Colon, Kidney, Other genitourinary, Pancreas, Rectum, Sarcoma

View Trial Details

CLINICAL TRIAL 20898

A Modular Phase 2a Multicentre Open-Label Study to Investigate DNA-damage Response Agents (or Combinations) in Patients With Advanced Cancer Whose Tumours Contain Molecular Alterations (PLANETTE)

Disease Site: Any Site, Breast, Colorectal, Endometrial/Uterine, Extrapulmonary small cell lung cancer, Gallbladder, Gastric / Stomach, Gastrinoma, Gastrointestinal, Liver, Lung, Non small cell lung cancer, Other genitourinary, Other GI, Pancreas, Prostate, Reproductive System, Urinary Bladder, Uterus

View Trial Details

CLINICAL TRIAL 20911

MRI Guided Adaptive Radiation for Locally Advanced Rectal Adenocarcinoma to Enhance Complete Response

Disease Site: Rectum

View Trial Details

CLINICAL TRIAL 21180

A First-in-Human, Two-Part, Open-Label, Clinical Study to Assess the Safety, Tolerability and Activity of Intravenous Doses of ICT01 as Monotherapy and in Combination with an Immune Checkpoint Inhibitor, in Patients with Advanced-Stage, Relapsed/Refractory Cancer (EVICTION Study)

Disease Site: Any Site, Breast, Colon, Larynx, Leukemia, other, Lip, Oral Cavity and Pharynx, Lung, Melanoma, skin, Ovary, Prostate, Stomach, Urinary Bladder

View Trial Details

CLINICAL TRIAL 21336

A Phase I/Ib Global, Multicenter, Open-Label Umbrella Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients with Metastatic Colorectal Cancer (Intrinsic)

Disease Site: Colon

View Trial Details

CLINICAL TRIAL 21459

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease (CIRCULATE-US)

Disease Site: Colon

View Trial Details

CLINICAL TRIAL 21565

An Open-Label, Multi-center, Phase II Platform Study Evaluating the Efficacy and Safety of NIS793 and Other New Investigational Drug Combinations with Standard of Care (SOC) Anti-Cancer Therapy for the Second Line Treatment of Metastatic Colorectal Cancer (mCRC)

Disease Site: Colon, Rectum

View Trial Details

CLINICAL TRIAL 21636

A Dose-Escalation and Expansion Study of the Safety and Efficacy of XL092 in Combination with Immuno-Oncology Agents in Subjects with Unresectable Advanced or Metastatic Solid Tumors

Disease Site: Breast, Colon, Prostate, Urinary Bladder

View Trial Details

CLINICAL TRIAL 21712

A Phase 2 Open Label Study to Evaluate the Safety and Effectiveness of 212Pb-DOTAMTATE in PRRT Naïve Subjects with Somatostatin Receptor Expressing Neuroendocrine Tumors

Disease Site: Any Site, Liver, Lung, Other Digestive Organ, Other Endocrine System, Pancreas, Rectum, Small Intestine, Stomach

View Trial Details

CLINICAL TRIAL 21945

Phase 2, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Topically Administered LUT014 in Metastatic Colorectal Cancer Patients with EGFR Inhibitor Induced Acneiform Lesions Protocol

Disease Site: Colon

View Trial Details

CLINICAL TRIAL 22117

STRONG-PD: Support Through Remote Observation And Nutrition Guidance (STRONG) Program For Cancer Patients With Peritoneal Disease

Disease Site: Colon, Other Digestive Organ

View Trial Details

CLINICAL TRIAL 16028

Transdisciplinary Research in Colorectal Cancer: The ColoCare Study

Disease Site: Colorectal, Colon, Rectum

View Trial Details

CLINICAL TRIAL 21589

BASECAMP-1: An Observational Study Obtaining Solid Tumor Tissue from Subjects with Primary Surgical Resection and Leukapheresis for CAR T-Cell Therapy Manufacturing

Disease Site: Breast, Colon, Esophagus, Lip, Oral Cavity and Pharynx, Lung, Ovary, Pancreas, Rectum, Stomach

View Trial Details

CLINICAL TRIAL 22176

Pilot to Create and Refine eHealth Genetic Education for Early-Onset Colorectal Cancer Patients (Nest-CRC Pilot)

Disease Site: Colon, Rectum

View Trial Details